Regulates the sale of methamphetamine precursor drugs in New York.
This bill amends the general business law to regulate the sale of methamphetamine precursor drugs. It mandates that businesses selling these drugs must implement a real-time stop sale system to prevent illegal purchases. The system must be free of charge, communicate with other states, and generate stop sale alerts. Sellers must electronically submit purchase information to the system. The bill sets limits on the quantity of ephedrine and pseudoephedrine that can be sold to a single person per day and per month.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.